Related Experiment Video
Updated: Jul 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies
Harald Bär1, Bertrand Goudeau, Sarah Wälde
1Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
Abstract:
Myofibrillar myopathy (MFM) encompasses a genetically heterogeneous group of human diseases caused by mutations in genes coding for structural proteins of muscle. Mutations in the intermediate filament (IF) protein desmin (DES), a major cytoskeletal component of myocytes, lead to severe forms of "desminopathy," which affects cardiac, skeletal, and smooth muscle. Most mutations described reside in the central alpha-helical rod domain of desmin. Here we report three novel mutations--c.1325C>T (p.T442I), c.1360C>T (p.R454W), and c.1379G>T (p.S460I)--located in desmin's non-alpha-helical carboxy-terminal "tail" domain. We have investigated the impact of these and four--c.1237G>A (p.E413K), c.1346A>C (p.K449T), c.1353C>G (p.I451M), and c.1405G>A (p.V469M)--previously described "tail" mutations on in vitro filament formation and on the generation of ordered cytoskeletal arrays in transfected myoblasts. Although all but two mutants (p.E413K, p.R454W) assembled into IFs in vitro and all except p.E413K were incorporated into IF arrays in transfected C2C12 cells, filament properties differed significantly from wild-type desmin as revealed by viscometric assembly assays. Most notably, when coassembled with wild-type desmin, these mutants revealed a severe disturbance of filament-formation competence and filament-filament interactions, indicating an inherent incompatibility of mutant and wild-type protein to form mixed filaments. The various clinical phenotypes observed may reflect altered interactions of desmin's tail domain with different components of the myoblast cytoskeleton leading to diminished biomechanical properties and/or altered metabolism of the individual myocyte. Our in vitro assembly regimen proved to be a very sensible tool to detect if a particular desmin mutation is able to cause filament abnormalities.
Insights
Mutations in the desmin (DES) gene's tail domain disrupt intermediate filament formation, causing desminopathy. These desmin mutations show incompatibility with wild-type desmin, impacting muscle cell structure and function.
Area of Science:
- Muscle biology
- Cellular and molecular biology
- Genetics
Background:
- Myofibrillar myopathies (MFM) are a group of genetic muscle disorders.
- Mutations in the desmin (DES) gene cause severe desminopathy, affecting cardiac, skeletal, and smooth muscles.
- Most known mutations are in the desmin rod domain; this study focuses on the tail domain.
Observation:
- Three novel and four previously described desmin tail domain mutations were analyzed.
- Mutant desmin proteins were studied for in vitro filament formation and cytoskeletal array assembly in myoblasts.
- Viscometric assembly assays revealed significant differences in filament properties compared to wild-type desmin.
Findings:
- Most tail domain mutants assembled into intermediate filaments (IFs) in vitro and were incorporated into IF arrays in transfected cells.
- Mutants displayed altered filament formation competence and filament-filament interactions when coassembled with wild-type desmin.
- An inherent incompatibility between mutant and wild-type desmin proteins was observed in mixed filaments.
Implications:
- Desmin tail domain mutations can lead to desminopathy by disrupting cytoskeletal structure and function.
- Altered interactions with other cytoskeletal components may explain diverse clinical phenotypes.
- In vitro assembly assays are effective for identifying desmin mutations that cause filament abnormalities.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Desmosomes
Cardiomyopathy III: Hypertrophic Cardiomyopathy
The Sarcomere
Each myosin...
Overview of Myosin Structure and Function
Cardiomyopathy I: Introduction and Classification
